Infectious Disease Diagnostics Market Forecast to 2028

Report Code : TIPHE100001430 | Region : Global | Industry : Biotechnology | Published Date : 21/Apr/2022
Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Kits and Reagents, Instruments, and Software and Service ss), Disease Indication [HIV, Hepatitis, Healthcare- Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others Disease Indications ], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and, Point of Care Testing), End User (Hospitals and Clinics, Pathology or Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others End User), and Geography

The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed to increased government funding, rising healthcare costs, and the increasing adoption of technologically advanced diagnostic equipment in healthcare organizations. However, the tedious and expensive process of infectious disease diagnostics development is restricting the infectious disease diagnostics market growth.

Infectious disease diagnosis is a diagnostic procedure for detecting the presence of foreign antigens / organisms with the help of various diagnostic tools that are executed with the help of skilled technicians or physicians. The blood, urine, mucus, or other body fluids sample is analyzed to provide information about the organism causing the infection by using various diagnostic procedures and instruments.

Infectious diseases are caused by infectious agents, such as viruses, bacteria, parasites, fungi, and toxic products. HIV is a major global public health issue across the world. According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), ~ 37.7 million people had were HIV positive in 2020, . Out of these,out of which 1.7 million were children aged below 0–14 years, and 36 million were adults. AlsoFurther, more than half (~53%) were girls and women. ~1.5 million new HIV cases were reported in 2020 globally. Similarly, Hhepatitis is inflammation of the liver caused by a viral infection. The five main strains of hepatitis viruses are A, B, C, D, and E. According to World Health Organization (WHO), ~around 58 million people across the globe have chronic hepatitis C virus infection, and ~1.5 million new infections occur every year.

According to WHO, tuberculosis (TB) is the thirteenth-highest death-causing disease globally and the second leading infectious disease after COVID-19. As per WHO, 1.5 million deaths were caused by TB in 2020 (including 214,000 people affected by HIV). In 2020, WHO projected that 10 million people had TB globally, including 1.1 million children, 3.3 million women, and 5.6 million men. TB is present in all age groups and countries. Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Eight countries make up two-thirds of the total , with India at the forefront, followed by China, the Philippines, Indonesia, Nigeria, Pakistan, Bangladesh, and South Africa.

Based on product, the global infectious disease diagnostics market , based on product, has beenis segmented into kits and reagents, instruments, and software and services . In 2021, the kits and reagents held the largest share of the market, by product. However, the software and services segment are is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028. Based on disease indication, the global infectious disease diagnostics market , based on disease indication, is segmented into HIV, hepatitis, healthcare- associated infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, and others disease indications. The hepatitis segment held the largest share of the market in 2021. However, the healthcare- associated infections (HAIs) segment is anticipated to register the highest CAGR during the forecast period. Based on technology, the global infectious disease diagnostics market , based on technology, has beenis segmented into immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics segment held the largest share of the market, by technology. However, the next generation sequencing segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028. Based on testing type, the global infectious disease diagnostics market, based on testing type, has been is segmented bifurcated into laboratory testing and point of- care testing immunodiagnostics, polymerase chain reaction, next generation sequencing, clinical microbiology, and others. In 2021, the immunodiagnostics laboratory testing segment held the largest share of the market, by testing type. However, the next generation sequencingpoint -of -care testing segment is expected to witness growth in its demand at a fastest CAGR during 2021 to 2028. Based on end user, the global infectious disease diagnostics market is, based on end user, has been segmented into hospitals & clinics, pathology or diagnostic laboratories, research institutes, home care settings, and others. In 2021, the pathology or diagnostic laboratories segment held the largest share of the market, by end user. However, the home care settings segment is expected to witness growth in its demand at a fastestregister the highest CAGR during from 2021 to 2028.

COVID-19 Impact – Infectious Disease Diagnostics Market

The current COVID-19 pandemic has sparkedled to a surge inincreased demand for various point-of-care testing (POCT) diagnostic kits, which provide for early detection and help control the spread of COVID-19of coronavirus spread. SARS-CoV-2 screening diagnostics are constantly being developed to meet the needs of markets with unique regulatory constraints. For example, in February 2022, Mylab Discovery Solutions launched CoviSwift, a point-of-care (POC) RT-PCR testing solution that may be utilized in-hospital labs, small labs, airports, and communities. Moreover, iIn November 2021, Detect launched a new PCR-quality at-home COVID-19 quick molecular test to address testing needs at work, home, and school in the United Statesin the US at work, home, and schools. LikewiseSimilarly, in March 2020, BioMedomics released a PoC COVID-19 test that can identify antibodies in blood within 15 minutes. Also, Iin March 2022, SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced the completion of the diagnostic research project PoC-BoSens led by the Fraunhofer Institute for Reliability and Microintegration (IZM). The PoC-BoSens platform is a revolutionary label-free point-of-care device based on three-dimensional photonic bottle resonators (3D-BMRs) for real-time high-sensitive measurement of disease-relevant biomolecules. As a result, the demand need for infectious disease diagnostic products is rising, with an increasing number ofmany people suffering from coronavirusCOVID-19. Several Many diagnostic laboratories and testing facilities are also being launched that are expanding the scope of the market. For instance, in June 2020, the Union Minister of Health and Family Welfare launched India’s first mobile I-Lab (Infectious disease diagnostic lab) for COVID-19 testing. Such developments are anticipated to boost the demand for infectious disease diagnostic products in the near futurecoming years. Thus, the pandemic has had a profound impact onprofoundly impacted the public health profession. ThusTherefore, increased production by the companies has resulted in profits, and the outbreak of COVID-19 outbreak has shown a positive impact onpositively impacted the infectious disease diagnostyics market growth.

Various organic and inorganic strategies are adopted by companies in the infectious disease diagnostics market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies have allowed the infectious disease diagnostics market players to expand their business, enhance their geographic presence, and contribute to the overall market growth. Further, growth strategies, such as acquisitions and partnerships, helped the market playersstrengthen their customer base and extend product portfolios. A few of the significant developments by key players in the infectious disease diagnostics market are listed below.

In January 2022, Cepheid announced that Health Canada issued Cepheid a medical device license for Xpert Xpress CoV-2/Flu/RSV plus, a rapid molecular diagnostic test for the qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and respiratory syncytial virus (RSV) infections from a single patient sample.

In April 2020, CerTest Biotec and BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2 Real-Time PCR Detection Kit adapted for the BD MAX System has been CE marked to the IVD Directive (98/79/CE). The molecular test for the detection of COVID-19 is available to clinical laboratories in countries recognizing the CE mark.

A few of the major primary and secondary sources referred to while preparing the report on the infectious disease diagnostics market are the European Federation of Pharmaceutical Industries and Associations (EFPIA), the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Department of Biotechnology (DBT).

List of Companies:

1. Danaher

2. Abbott

3. BD

4. Trinity Biotech

5. F. HOFFMANN-LA ROCHE LTD.

6. Cardinal Health Inc

7. bioMerieux SA

8. BIO-RAD LABORATORIES INC.

9. AccuBioTech Co., Ltd.

10. ACON Laboratories, Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Infectious Disease Diagnostics Market – By Product

1.3.2 Global Infectious Disease Diagnostics Market – By Technology

1.3.3 Global Infectious Disease Diagnostics Market – By Testing Type

1.3.4 Global Infectious Disease Diagnostics Market – By Disease Indication

1.3.5 Global Infectious Disease Diagnostics Market – By End User

1.3.6 Global Infectious Disease Diagnostics Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Infectious Disease Diagnostics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South And Central America PEST Analysis

4.3 Experts Opinion

5. Infectious Disease Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Infectious Disease

5.1.2 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics

5.2 Market Restraints

5.2.1 Inadequate Reimbursement Scenario

5.3 Market Opportunities

5.3.1 Growing Opportunities in Developing Nations

5.4 Future Trend

5.4.1 Rising Number of Product Approvals and Launches

5.5 Impact Analysis

6. Infectious Disease Diagnostics Market– Global Analysis

6.1 Global Infectious Disease Diagnostics Market Revenue Forecast and Analysis

6.1.1 Global Infectious Disease Diagnostics Market Revenue Forecast and Analysis

6.1.2 Global Infectious Disease Diagnostics Market – Market Potential Analysis, By Region

6.2 Market Positioning Analysis of Key Players in Infectious Disease Diagnostics Market

6.2.1 Company Analysis

6.2.2 Growth Strategy Analysis

6.2.3 Performance of Key Players

6.2.3.1 F.Hoffmann-La Roche Ltd.

6.2.3.2 Abbott Laboratories

7. Global Infectious Disease Diagnostics Market Revenue and Forecast To 2028– by Product

7.1 Overview

7.2 By Product: Market Revenue and Forecast Analysis (US$ Million)

7.3 Kits and Reagents

7.3.1 Overview

7.3.2 Kits and Reagents Market Revenue and Forecast to 2028 (US$ Million)

7.4 Instruments

7.4.1 Overview

7.4.2 Instruments Market Revenue and Forecast to 2028 (US$ Million)

7.5 Software and Services

7.5.1 Overview

7.5.2 Software and Services Market Revenue and Forecast to 2028 (US$ Million)

8. Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Technology

8.1 Infectious Disease Diagnostics Market Revenue Share, by Technology (2021 and 2028)

8.2 Immunodiagnostics

8.2.1 Overview

8.2.2 Immunodiagnostics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 PCR: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Next Generation Sequencing

8.4.1 Overview

8.4.2 Next Generation Sequencing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Clinical Microbiology

8.5.1 Overview

8.5.2 Clinical Microbiology: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9. Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Testing Type

9.1 Infectious Disease Diagnostics Market Revenue Share, by Testing Type (2021 and 2028)

9.2 Laboratory Testing

9.2.1 Overview

9.2.2 Laboratory Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Point of Care Testing

9.3.1 Overview

9.3.2 Point-of-Care Testing: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10. Global Infectious Disease Diagnostics Market Analysis and Forecast to 2028 – by Disease Indication

10.1 Overview

10.2 Infectious Disease Diagnostics Market Revenue Share, by Disease Indication (2021 and 2028)

10.3 HIV

10.3.1 Overview

10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)

10.4 Hepatitis

10.4.1 Overview

10.4.2 Hepatitis Market Revenue and Forecast to 2028 (US$ Million)

10.5 Healthcare Associated Infections (HAIs)

10.5.1 Overview

10.5.2 Hospital Associated Infections (HAIs) Market Revenue and Forecast to 2028 (US$ Million)

10.6 Human Papillomavirus (HPV)

10.6.1 Overview

10.6.2 Human Papillomavirus (HPV) Market Revenue and Forecast to 2028 (US$ Million)

10.7 Tuberculosis (TB)

10.7.1 Overview

10.7.2 Tuberculosis (TB) Market Revenue and Forecast to 2028 (US$ Million)

10.8 Influenza

10.8.1 Overview

10.8.2 Influenza Market Revenue and Forecast to 2028 (US$ Million)

10.9 Others

10.9.1 Overview

10.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

11. Infectious Disease Diagnostics Market Analysis – by End User

11.1 Overview

11.2 Infectious Disease Diagnostics Market Revenue Share, by End User (2021 and 2028)

11.3 Hospitals and Clinics

11.3.1 Overview

11.3.2 Hospitals and Clinics: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Pathology or Diagnostic Laboratories

11.4.1 Overview

11.4.2 Pathology or Diagnostics Laboratories: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Research Institutes

11.5.1 Overview

11.5.2 Research Institutes: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Home Care Settings

11.6.1 Overview

11.6.2 Home Care Settings: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.7 Others

11.7.1 Overview

11.7.2 Others: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12. Infectious Disease Diagnostics Market Revenue and Forecast to 2028 – Geographical Analysis

12.1 North America: Infectious Disease Diagnostics Market

12.1.1 Overview

12.1.2 North America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.3 North America: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.4 North America: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.5 North America: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.6 North America: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.7 North America: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8 North America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.1.8.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.1 US: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.2 US: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.1.3 US: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.1.4 US: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.1.5 US: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.1.6 US: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8.2 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.1 Canada: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.2 Canada: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.2.3 Canada: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.2.4 Canada: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.2.5 Canada: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.2.6 Canada: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.1.8.3 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.1 Mexico: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.2 Mexico: Infectious Disease Diagnostics Market, by Product, 2019–2028 (US$ Million)

12.1.8.3.3 Mexico: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (US$ Million)

12.1.8.3.4 Mexico: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (US$ Million)

12.1.8.3.5 Mexico: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (US$ Million)

12.1.8.3.6 Mexico: Infectious Disease Diagnostics Market, by End User, 2019–2028 (US$ Million)

12.2 Europe: Infectious Disease Diagnostics Market

12.2.1 Overview

12.2.2 Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3 Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.4 Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.5 Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.6 Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.7 Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8 Europe: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.2.8.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.1 Germany: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.2 Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.3 Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.4 Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.5 Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.6 Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.1 France: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.2 France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.3 France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.4 France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.5 France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.6 France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.1 UK: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.2 UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.3 UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.4 UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.5 UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.6 UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.1 Italy: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.2 Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.3 Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.4 Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.5 Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.6 Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.1 Spain: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.2 Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.3 Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.4 Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.5 Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.6 Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.1 Rest of Europe: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.2 Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.3 Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.4 Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.5 Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.6 Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3 Asia Pacific: Infectious Disease Diagnostics Market

12.3.1 Overview

12.3.2 Asia Pacific: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.3.3 Asia Pacific: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.4 Asia Pacific: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.3.5 Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.3.6 Asia Pacific: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.3.7 Asia Pacific: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8 Asia Pacific: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.3.8.1 China: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.1.1 China: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.1.2 China: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.1.3 China: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.3.8.1.4 China: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.3.8.1.5 China: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.3.8.1.6 China: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.2 Japan: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.2.1 Japan: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.2.2 Japan: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.2.3 Japan: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.2.4 Japan: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.2.5 Japan: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.2.6 Japan: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.3 India: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.3.1 India: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.3.2 India: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.3.3 India: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.3.4 India: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.3.5 India: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.3.6 India: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.4 Australia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.4.1 Australia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.4.2 Australia: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.4.3 Australia: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.4.4 Australia: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.4.5 Australia: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.4.6 Australia: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.5 South Korea: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.5.1 South Korea: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.5.2 South Korea: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.5.3 South Korea: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.5.4 South Korea: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.5.5 South Korea: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.5.6 South Korea: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.3.8.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.6.1 Rest of Asia Pacific: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.3.8.6.2 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Product, 2019–2028 (USD Million)

12.3.8.6.3 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Technology, 2019–2028 (USD Million)

12.3.8.6.4 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Testing Type, 2019–2028 (USD Million)

12.3.8.6.5 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Disease Indication, 2019–2028 (USD Million)

12.3.8.6.6 Rest of Asia Pacific: Infectious Disease Diagnostics Market, By End User, 2019–2028 (USD Million)

12.4 Middle East and Africa: Infectious Disease Diagnostics Market

12.4.1 Overview

12.4.2 Middle East & Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

12.4.3 Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.4 Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.5 Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.6 Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.7 Middle East & Africa: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8 Middle East & Africa: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.4.8.1 Saudi Arabia: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.1.1 Saudi Arabia: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.1.2 Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.1.3 Saudi Arabia: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.1.4 Saudi Arabia: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.1.5 Saudi Arabia: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.1.6 Saudi Arabia: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.2 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.1 UAE: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.2 UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.3 UAE: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.2.4 UAE: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.2.5 UAE: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.2.6 UAE: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.3 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.1 South Africa: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.2 South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.3 South Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.3.4 South Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.3.5 South Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.3.6 South Africa: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.4.8.4 Rest of Middle East and Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.4.1 Rest of Middle East and Africa: Infectious Disease Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

12.4.8.4.2 Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

12.4.8.4.3 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.4.8.4.4 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.4.8.4.5 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.4.8.4.6 Rest of Middle East & Africa: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5 South and Central America Infectious Disease Diagnostics Market Revenue and Forecast To 2028

12.5.1 Overview

12.5.2 South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.3 South and Central America: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.4 South and Central America: Infectious Disease Diagnostics Market, by Technology, 2019–2028 (USD Million)

12.5.5 South and Central America: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.5.6 South and Central America: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.7 South and Central America: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8 South and Central America: Infectious Disease Diagnostics Market, by Country, 2021 & 2028 (%)

12.5.8.1 Brazil: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.1.1 Brazil: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.1.2 Brazil: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.1.3 Brazil: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.1.4 Brazil: Infectious Disease Diagnostics Market, by Testing Type, 2019–2028 (USD Million)

12.5.8.1.5 Brazil: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.8.1.6 Brazil: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8.2 Argentina: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.2.1 Argentina: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.2.2 Argentina: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.2.3 Argentina: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.2.4 Argentina: Infectious Disease Diagnostics Market , by Testing Type, 2019–2028 (USD Million)

12.5.8.2.5 Argentina: Infectious Disease Diagnostics Market, by Disease Indication, 2019–2028 (USD Million)

12.5.8.2.6 Argentina: Infectious Disease Diagnostics Market, by End User, 2019–2028 (USD Million)

12.5.8.3 Rest of South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.3.1 Rest of South and Central America: Infectious Disease Diagnostics Market – Revenue and Forecast to 2028 (USD Million)

12.5.8.3.2 Rest of South and Central America: Infectious Disease Diagnostics Market , by Product, 2019–2028 (USD Million)

12.5.8.3.3 Rest of South and Central America: Infectious Disease Diagnostics Market , by Technology, 2019–2028 (USD Million)

12.5.8.3.4 Rest of South and Central America: Infectious Disease Diagnostics Market , by Testing Type, 2019–2028 (USD Million)

12.5.8.3.5 Rest of South and Central America: Infectious Disease Diagnostics Market , by Disease Indication, 2019–2028 (USD Million)

12.5.8.3.6 Rest of South and Central America: Infectious Disease Diagnostics Market , by End User, 2019–2028 (USD Million)

13. Impact Of COVID-19 Pandemic on Infectious Disease Diagnostics Market

13.1 North America: Impact Assessment of COVID-19 Pandemic

13.2 Europe: Impact Assessment of COVID-19 Pandemic

13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Infectious Disease Diagnostics Market–Industry Landscape

14.1 Overview

14.2 Growth Strategies in the Infectious Disease Diagnostics Market

14.3 Organic Developments

14.3.1 Overview

14.4 Inorganic Developments

14.4.1 Overview

15. Company Profiles

15.1 Danaher

15.1.1 Key Facts

15.1.2 Business Description

15.1.3 Products and Services

15.1.4 Financial Overview

15.1.5 SWOT Analysis

15.1.6 Key Developments

15.2 Abbott

15.2.1 Key Facts

15.2.2 Business Description

15.2.3 Products and Services

15.2.4 Financial Overview

15.2.5 SWOT Analysis

15.2.6 Key Developments

15.3 BD

15.3.1 Key Facts

15.3.2 Business Description

15.3.3 Products and Services

15.3.4 Financial Overview

15.3.5 SWOT Analysis

15.3.6 Key Developments

15.4 Trinity Biotech

15.4.1 1.4.1 Key Facts

15.4.2 Business Description

15.4.3 Products and Services

15.4.4 Financial Overview

15.4.5 SWOT Analysis

15.4.6 Key Developments

15.5 F. HOFFMANN-LA ROCHE LTD.

15.5.1 Key Facts

15.5.2 Business Description

15.5.3 Products and Services

15.5.4 Financial Overview

15.5.5 SWOT Analysis

15.5.6 Key Developments

15.6 Cardinal Health Inc.

15.6.1 1.6.1 Key Facts

15.6.2 Business Description

15.6.3 Products and Services

15.6.4 Financial Overview

15.6.5 SWOT Analysis

15.6.6 Key Developments

15.7 bioMerieux SA

15.7.1 Key Facts

15.7.2 Business Description

15.7.3 Products and Services

15.7.4 Financial Overview

15.7.5 SWOT Analysis

15.7.6 Key Developments

15.8 BIO-RAD LABORATORIES INC.

15.8.1 Key Facts

15.8.2 Business Description

15.8.3 Products and Services

15.8.4 Financial Overview

15.8.5 SWOT Analysis

15.8.6 Key Developments

15.9 AccuBioTech Co., Ltd.

15.9.1 Key Facts

15.9.2 Business Description

15.9.3 Products and Services

15.9.4 Financial Overview

15.9.5 SWOT Analysis

15.9.6 Key Developments

15.10 ACON Laboratories, Inc.

15.10.1 Key Facts

15.10.2 Business Description

15.10.3 Products and Services

15.10.4 Financial Overview

15.10.5 SWOT Analysis

15.10.6 Key Developments

16. Appendix

16.1 About The Insight Partners

16.2 Glossary of Terms in Infectious Disease Diagnostics Market

LIST OF TABLES.

Table 1. Infectious Diseases and Funding

Table 2. North America Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 4. North America Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6. North America Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 26. Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31. Germany: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 36. France: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 41. UK: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 45. Italy: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 46. Italy: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 51. Spain: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Europe: Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Europe: Infectious Disease Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Europe: Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (US$ Million)

Table 55. Rest of Europe: Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 56. Rest of Europe: Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 57. Asia Pacific: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 58. Asia Pacific: Infectious Disease Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 59. Asia Pacific: Infectious Disease Diagnostics Market, by Testing Type– Revenue and forecast to 2028 (USD Million)

Table 60. Asia Pacific: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and forecast to 2028 (USD Million)

Table 61. Asia Pacific: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 62. China: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 63. China: Infectious Disease Diagnostics Market, by Technology– Revenue and forecast to 2028 (USD Million)

Table 64. China: Infectious Disease Diagnostics Market, by Testing Type– Revenue and forecast to 2028 (USD Million)

Table 65. China: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and forecast to 2028 (USD Million)

Table 66. China: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 67. Japan: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 68. Japan: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 69. Japan: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 70. Japan: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 71. Japan: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 72. India: Infectious Disease Diagnostics Market, By Product– Revenue and Forecast to 2028 (USD Million)

Table 73. India: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 74. India: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 75. India: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 76. India: Infectious Disease Diagnostics Market, By End User– Revenue and Forecast to 2028 (USD Million)

Table 77. Australia: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 78. Australia: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 79. Australia: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 80. Australia: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 81. Australia: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 82. South Korea: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 83. South Korea: Infectious Disease Diagnostics Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 84. South Korea: Infectious Disease Diagnostics Market, By Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 85. South Korea: Infectious Disease Diagnostics Market, By Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 86. South Korea: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 87. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 88. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 89. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 90. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 91. Rest of Asia Pacific: Infectious Disease Diagnostics Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 92. Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 93. Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 94. Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 95. Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 96. Middle East & Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 97. Saudi Arabia Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 98. Saudi Arabia Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 99. Saudi Arabia Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 100. Saudi Arabia Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 101. Saudi Arabia Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 102. UAE Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 103. UAE Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 104. UAE Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 105. UAE Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 106. UAE Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 107. South Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 108. South Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 109. South Africa Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2028 (USD Million)

Table 110. South Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 111. South Africa Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 112. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 113. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 114. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 115. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 116. Rest of Middle East & Africa Infectious Disease Diagnostics Market, by Disease Indication – Revenue and Forecast to 2028 (USD Million)

Table 117. South and Central America: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 118. South and Central America: Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

Table 119. South and Central America: Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 120. South and Central America: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 121. South and Central America: Infectious Disease Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 122. Brazil: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 123. Brazil: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 124. Brazil: Infectious Disease Diagnostics Market, by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 125. Brazil: Infectious Disease Diagnostics Market, by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 126. Brazil: Infectious Disease Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 127. Argentina: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 128. Argentina: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 129. Argentina: Infectious Disease Diagnostics Market , by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 130. Argentina: Infectious Disease Diagnostics Market , by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 131. Argentina: Infectious Disease Diagnostics Market , by End User– Revenue and Forecast to 2028 (USD Million)

Table 132. Rest of South and Central America: Infectious Disease Diagnostics Market , by Product – Revenue and Forecast to 2028 (USD Million)

Table 133. Rest of South and Central America: Infectious Disease Diagnostics Market , by Technology – Revenue and Forecast to 2028 (USD Million)

Table 134. Rest of South and Central America: Infectious Disease Diagnostics Market , by Testing Type– Revenue and Forecast to 2028 (USD Million)

Table 135. Rest of South and Central America: Infectious Disease Diagnostics Market , by Disease Indication– Revenue and Forecast to 2028 (USD Million)

Table 136. Rest of South and Central America: Infectious Disease Diagnostics Market , by End User– Revenue and Forecast to 2028 (USD Million)

Table 137. Organic Developments Done By Companies

Table 138. Inorganic Developments Done By Companies

Table 139. Glossary of Terms in Infectious Disease Diagnostics Market

List of Companies:

1. Danaher

2. Abbott

3. BD

4. Trinity Biotech

5. F. HOFFMANN-LA ROCHE LTD.

6. Cardinal Health Inc

7. bioMerieux SA

8. BIO-RAD LABORATORIES INC.

9. AccuBioTech Co., Ltd.

10. ACON Laboratories, Inc.

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infectious disease diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Infectious Disease Diagnostics Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry